Position in DNLI
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$11,574
+$2,934 QoQ
Shares Held
450
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#232
of 290 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in DNLI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Owl Creek Wealth Partners LLC holds $664,212 across 37 Biotechnology names. DNLI ranks #15 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
285 | $141,568 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
118 | $73,577 | |
| 3 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
615 | $50,128 | |
| 4 | ARGX |
Argenx SE
|
50 | $46,388 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
150 | $45,154 | |
| 6 | MRNA |
Moderna, Inc.
|
576 | $40,337 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
165 | $30,901 | |
| 8 | INCY |
Incyte Corp
|
250 | $28,340 |
All Filings in DNLI
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,574 | 450 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $8,640 | 450 | Shares | Sole | 2026-05-14 | |
| No filing history on record for this holder in this stock. | ||||||